Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Ophthalmic Epidemiol ; 31(2): 99-106, 2024 Apr.
Article in English | MEDLINE | ID: mdl-37073137

ABSTRACT

PURPOSE: Reducing childhood blindness and vision impairment (BVI) remains a global health priority. Our purpose was to summarize the peer-reviewed literature to date on measuring and reporting childhood BVI using population-based surveys and vision examinations. METHODS: We conducted a scoping review of published studies that aimed to report BVI prevalence in children or studies that aimed to report BVI prevalence in the general population but which also included children. There were 201 articles identified for abstract review, and 86 studies were included in the final review. RESULTS: There were 52 studies (60%) that specifically aimed to investigate prevalence of blindness and/or vision impairment among child populations, while the remaining 34 studies aimed to study BVI in the general population but still reported data for age ranges that included children. The majority of researchers used the WHO criteria for blindness and vision impairment, sometimes with modifications. Age definitions for children varied considerably, with maximum cutoffs ranging from 3 to 20 years. CONCLUSION: The available literature on childhood blindness indicates that while there has been substantial progress towards establishing an evidence base, more remains to be accomplished in terms of addressing gaps in understanding of the true prevalence and impacts of childhood blindness and vision loss. All studies in this review cited the need for improved vision care services, either for all ages or for the childhood years in particular.


Subject(s)
Blindness , Vision, Low , Child , Humans , Child, Preschool , Adolescent , Young Adult , Adult , Visual Acuity , Blindness/epidemiology , Vision, Low/epidemiology , Vision Disorders , Prevalence
2.
Cornea ; 38(12): 1602-1609, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31433359

ABSTRACT

PURPOSE: This study seeks to review published research on the global epidemiology of corneal blindness, with a specific focus on the available published estimates of incidence, prevalence, and trends in incidence or prevalence, as well as the contribution of corneal causes to overall burden of blindness. METHODS: A scoping review was conducted of the published literature on the global epidemiology of corneal blindness, with emphasis on prevalence and incidence studies. Four databases were searched using both epidemiological and corneal blindness keywords. This review was limited to studies with a primary aim of determining the incidence, prevalence, or trends in corneal blindness or the percentage of blindness due to corneal causes. Only conditions considered to signify current blindness were included, not diseases that eventually could lead to blindness if left untreated. RESULTS: A total of 185 articles met the selection criteria. Of these, 145 articles investigated all-cause blindness prevalence. Only 10 articles specifically aimed to determine estimates of corneal blindness prevalence, 7 articles provided results for all-cause blindness incidence, and no studies focused on obtaining corneal blindness incidence. Data on corneal blindness were most often present in studies investigating all-cause blindness and in trachoma studies. CONCLUSIONS: The results demonstrate the somewhat inconsistent and fragmented information regarding corneal causes of vision loss. A significant outcome of this research is the demonstration of a need for further research into global corneal blindness and the necessary steps to address the problem.


Subject(s)
Blindness/epidemiology , Corneal Diseases/epidemiology , Global Health , Humans , Incidence , Prevalence
3.
J Health Care Finance ; 37(4): 46-70, 2011.
Article in English | MEDLINE | ID: mdl-21812354

ABSTRACT

Following efforts at addressing health care reform that spanned decades, the US Congress passed massive health reform legislation in 2010, with key provisions to be implemented over the next few years. This legislation has been heralded as the ultimate legislative response to the spiraling cost of care and inequity of access to care. Yet, these reforms have left many unanswered questions about the perennial issue of tort reform, in particular, caps on non-economic damages. This article begins with a broad perspective on tort reform and the debate surrounding the issue, and ends with a search for common ground where the threat of litigation may be reduced while the constitutional rights of citizens remain safeguarded.


Subject(s)
Health Facilities/legislation & jurisprudence , Health Personnel/legislation & jurisprudence , Health Services Accessibility/legislation & jurisprudence , Healthcare Disparities/legislation & jurisprudence , Patient Protection and Affordable Care Act/standards , Access to Information/legislation & jurisprudence , Cost Control/legislation & jurisprudence , Cost Control/methods , Government Regulation , Health Facilities/economics , Health Facilities/standards , Health Personnel/economics , Health Personnel/trends , Health Services Accessibility/economics , Healthcare Disparities/economics , Humans , Liability, Legal/economics , Patient Protection and Affordable Care Act/economics , Politics , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...